Literature DB >> 21412485

Anal fissure: a common cause of anal pain.

Herman Villalba, Sabrina Villalba, Maher A Abbas.   

Abstract

Entities:  

Year:  2007        PMID: 21412485      PMCID: PMC3048443          DOI: 10.7812/TPP/07-072

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


× No keyword cloud information.
  16 in total

1.  Incontinence after lateral internal sphincterotomy: a prospective study and quality of life assessment.

Authors:  Neil Hyman
Journal:  Dis Colon Rectum       Date:  2004-01-14       Impact factor: 4.585

2.  Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.

Authors:  Antonio Arroyo; Francisco Pérez; Pilar Serrano; Fernando Candela; Javier Lacueva; Rafael Calpena
Journal:  Am J Surg       Date:  2005-04       Impact factor: 2.565

3.  Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure.

Authors:  G Brisinda; F Cadeddu; F Brandara; G Marniga; G Maria
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

Review 4.  Aetiology and treatment of anal fissure.

Authors:  J N Lund; J H Scholefield
Journal:  Br J Surg       Date:  1996-10       Impact factor: 6.939

5.  Comparison of glycerine trinitrate and botulinum toxin-a for the treatment of chronic anal fissure: long-term results.

Authors:  Paola De Nardi; Enrico Ortolano; Giovanni Radaelli; Carlo Staudacher
Journal:  Dis Colon Rectum       Date:  2006-04       Impact factor: 4.585

6.  Open lateral internal anal sphincterotomy under local anesthesia as the gold standard in the treatment of chronic anal fissures. A prospective clinical and manometric study.

Authors:  A Sánchez Romero; A Arroyo Sebastián; F Pérez Vicente; P Serrano Paz; F Candela Polo; A Tomás Gómez; D Costa Navarro; A Fernández Frías; R Calpena Rico
Journal:  Rev Esp Enferm Dig       Date:  2004-12       Impact factor: 2.086

7.  Lateral internal sphincterotomy is superior to topical nitroglycerin for healing chronic anal fissure and does not compromise long-term fecal continence: six-year follow-up of a multicenter, randomized, controlled trial.

Authors:  Carl J Brown; Daniel Dubreuil; Laura Santoro; Maria Liu; Brenda I O'Connor; Robin S McLeod
Journal:  Dis Colon Rectum       Date:  2007-04       Impact factor: 4.585

8.  Open versus closed lateral sphincterotomy performed as an outpatient procedure under local anesthesia for chronic anal fissure: prospective randomized study of clinical and manometric longterm results.

Authors:  Antonio Arroyo; Francisco Pérez; Pilar Serrano; Fernando Candela; Rafael Calpena
Journal:  J Am Coll Surg       Date:  2004-09       Impact factor: 6.113

9.  Prevalence of benign anorectal disease in a randomly selected population.

Authors:  R L Nelson; H Abcarian; F G Davis; V Persky
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

10.  Diltiazem heals glyceryl trinitrate-resistant chronic anal fissures: a prospective study.

Authors:  Marion Jonas; William Speake; John H Scholefield
Journal:  Dis Colon Rectum       Date:  2002-08       Impact factor: 4.585

View more
  3 in total

1.  Sacral osteomyelitis as a rare cause of anorectal pain several years following treatment for rectal carcinoma.

Authors:  Darren C R Fernandes; Sangeetha Srinivasan; Hubert Jervoise N Andreyev
Journal:  Oxf Med Case Reports       Date:  2022-04-19

2.  Herbal medicine AnoSpray suppresses proinflammatory cytokines COX-2 and RANTES in the management of hemorrhoids, acute anal fissures and perineal wounds.

Authors:  Ashwin Porwal; Gopal C Kundu; Gajanan Bhagwat; Ramesh Butti
Journal:  Exp Ther Med       Date:  2021-11-25       Impact factor: 2.447

3.  The prevalence of proctological symptoms amongst patients who see general practitioners in France.

Authors:  Laurent Abramowitz; Mustapha Benabderrahmane; Dan Pospait; Julie Philip; Cédric Laouénan
Journal:  Eur J Gen Pract       Date:  2014-04-04       Impact factor: 1.904

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.